سعر اريكتاليس 20مجم 4 قرص 2025

Erectalis 20 mg (tadalafil) film-coated tablets, pack of 4, by Penta Pharma (Egypt).

• Treatment of erectile dysfunction.Population: Adult menDailyMed (U.S. National Library of Medicine)
• Treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), and of ED with BPH (labelled with once-daily low-dose regimens, not the 20 mg as-needed dose).Population: Adult menDailyMed (U.S. National Library of Medicine)

• Most common adverse reactions (≥ 2%) include headache, dyspepsia, back pain, myalgia, nasal congestion, flushing and pain in limb.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Use of any form of organic nitrate, either regularly and/or intermittently.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Known serious hypersensitivity reaction to tadalafil (Cialis or Adcirca).International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Concomitant use of guanylate cyclase stimulators such as riociguat.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Cardiovascular: evaluate cardiovascular status before prescribing; not to be used in men for whom sexual activity is inadvisable.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Use with alpha-blockers, antihypertensives or substantial alcohol (≥ 5 units) may lower blood pressure significantly and cause dizziness or syncope.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Prolonged erection (> 4 hours) or priapism require prompt medical attention.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Organic nitrates or nitric oxide donors in any formContraindicatedTadalafil potentiates the hypotensive effect of nitrates; contraindicated. If a nitrate is deemed medically necessary in a life-threatening situation, at least 48 hours should elapse after the last tadalafil dose, under close medical supervision.DailyMed (U.S. National Library of Medicine)
• Potent CYP3A4 inhibitors (e.g. ketoconazole, ritonavir)Increase tadalafil exposure; for as-needed use do not exceed 10 mg, not more than once every 72 hours.DailyMed (U.S. National Library of Medicine)
• Potent CYP3A4 inducers (e.g. rifampin)Decrease tadalafil exposure and may reduce efficacy.DailyMed (U.S. National Library of Medicine)

• Not indicated for use in females; no data in pregnant women, and no adverse developmental effects in rats or mice at exposures up to 11 times the maximum recommended human dose.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Not indicated for use in females; no information on presence in human milk; tadalafil and/or metabolites are present in rat milk at about 2.4-fold plasma concentrations.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Tadalafil: Inhibits PDE5, increasing cGMP in corpus cavernosum and prostate/bladder smooth muscle (US Cialis label).